John K Scott Jr. insider trades: Navidea Biopharmaceuticals (NAVB) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 30, 2020 | NAVB | ↑ Buy | 5,000 | $5.00 | $25K | Direct | Sep 2, 2020 (3d) |
| Feb 13, 2020 | NAVB | ↑ Buy | 2,373,529 | $0.85 | $2.0M | Direct | Feb 19, 2020 (6d) |
| Dec 6, 2019 | NAVB | ↑ Buy | 555,555 | $0.90 | $500K | Direct | Dec 11, 2019 (5d) |
| Jun 18, 2019 | NAVB | ↑ Buy | 4,000,000 | $0.75 | $3.0M | Direct | Jun 21, 2019 (3d) |
| Mar 22, 2019 | NAVB | ↑ Buy | 357,143 | $0.14 | $50K | Direct | Mar 25, 2019 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About John K Scott Jr.'s insider trades
John K Scott Jr. is an insider at Navidea Biopharmaceuticals (NAVB). Since Mar 22, 2019, John has reported 5 open-market purchases worth $5.6M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (15 filings), other transactions (5 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NAVB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.